About Us
Overview
Company Milestones
Our Facilities
Products
Medical Information
Contact Us
About Us
Overview
Company Milestones
Our Facilities
Products
Medical Information
Contact Us
2016 – Zydus’s Nesher Pharmaceuticals received its first ANDA approval, dextroamphetamine tablets
Post navigation
Previous:
2016 – Zydus received approval from the USFDA to initiate Phase II clinical trials of saroglitazar in patients with Non-Alcoholic Steatohepatitis (NASH) of the liver in the US
Next:
2017 – Zydus Cadila acquired Sentynl Therapeutics Inc., US-based specialty company